Arterial occlusive events during chemotherapy for germ cell cancer

Netherlands Journal of Medicine

Volumn 59, Issue 6, 2001, Pages 295-299

  Vos, A H ^a   Splinter, T A W ^b   Van Der Heul, C ^a  

^a Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Hypercoagulable state; Malignancy; Seminoma; Thromboembolic events

Indexed keywords

ACETYLSALICYLIC ACID; BLEOMYCIN; CISPLATIN; DEXAMETHASONE; ETOPOSIDE;

ADULT; ARTERY OCCLUSION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; GERM CELL TUMOR; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; MALE; PATHOGENESIS; REMISSION; RISK FACTOR; SEMINOMA; THROMBOEMBOLISM;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARTERIAL OCCLUSIVE DISEASES; BLEOMYCIN; CISPLATIN; ETOPOSIDE; HUMANS; MALE; MYOCARDIAL INFARCTION; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 0035659887     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(01)00173-5     Document Type: Article

References (25)

1. Testicular germ cell cancer
2. Transient left homonymous hemianopsia and encephalopathy following treatment with cisplatin,vinblastine and bleomycin
3. Pulmonary emboli as a complication of germ cell cancer treatment
4. Severe vascular toxicity associated with vinblastine, bleomycin and cisplatin chemotherapy
5. Thromboembolic events during combination chemotherapy for germ cell malignancy
6. Severe vascular toxicity associated with cisplatin-based chemotherapy
7. Arterial thrombosis in a patient after chemotherapy (BEP protocol) for extra-gonadal dysgerminoma
8. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ cell tumors of the testis
9. Thromboembolic events during combination chemotherapy for germ cell malignancy
10. Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastin, and bleomycin for testicular cancer
11. Combination chemotherapy with vinblastin, ifosfamide and cisplatin in bulky seminoma
12. Thromboembolic events during chemotherapy for germ cell cancer: A cohort study and review of the literature
13. Ten-years survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine and bleomycin
14. Human tumor procoagulants: Registry of the subcommittee on haemostasis and malignancy of the scientific and standardization committee, international society of thrombosis and haemostasis
15. Cancer procoagulant: A factor X activator, tumor marker and growth factor from malignant tissue
16. Characterization of the platelet-aggregating activity of tumor cells
17. Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell extracts, and cell surface sialylation in ten metastatic-variant derivates of a rat renal sarcoma line
18. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1
19. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
20. Effect of L-asparaginase therapy for acute lymphoblastic leukaemia on plasma vitamin K-dependent coagulation factors and inhibitors
21. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
22. Elevated plasma von Willebrand Factor levels and arterial occlusive complications associated with cisplatin based chemotherapy
23. Vitamin E prevents endothelial injury associated with cisplatin injection into the superior mesenteric artery of rats
24. Neoplastic venous involvement and pulmonary embolism in patients with germ cell tumors